Skip to content

A Registry of Peripartum Cardiomyopathy in Turkey

Clinical A Nation-wide Registry of Peripartum Cardiomyopathy: Clinical Status in Turkey

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03364140
Enrollment
50
Registered
2017-12-06
Start date
2017-07-02
Completion date
2018-01-15
Last updated
2017-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripartum Cardiomyopathy

Keywords

Peripartum Cardiomyopathy, Heart Failure

Brief summary

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

Detailed description

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in centres in Turkey. It is expected that approximately 50 women with PPCM will be recorded. The objectives of the study are: To define the clinical status and clinical characteristics of PPCM in Turkey To define the outcome of PPCM (short and long term) To define the demographical and possible etiological factors To define prognostic factors

Interventions

None listed

Sponsors

Turkish Society of Cardiology
CollaboratorOTHER
Ege University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patient above 18 years of age * Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period * Ejection fraction less than 45% documented with echocardiography

Exclusion criteria

* Patients with any other known cardiac pathology

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy outcome5 months after deliverymortality of the mother

Countries

Turkey (Türkiye)

Contacts

Primary ContactMeral Kayikcioglu, MD
meral.kayikcioglu@gmail.com+902323905448
Backup ContactMeral Kayikcioglu
meral.kayikcioglu@gmail.com+902323905448

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026